These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7092487)

  • 21. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R; Botting R; Coulson P; Spanswick G
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    Thomas JM; Rubin EH
    Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomania related to phenelzine and isoetharine interaction in one patient.
    Goldman LS; Tiller JA
    J Clin Psychiatry; 1987 Apr; 48(4):170. PubMed ID: 3558333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoclonus-associated hypomania during MAO-inhibitor treatment.
    Cohen RM; Pickar D; Murphy DL
    Am J Psychiatry; 1980 Jan; 137(1):105-6. PubMed ID: 7352541
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data.
    Riley LA; Denney RM
    Biochem Pharmacol; 1991 Oct; 42(10):1953-9. PubMed ID: 1741773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mania or hypomania after withdrawal from antidepressants.
    Hartmann PM
    J Fam Pract; 1990 Apr; 30(4):471-2. PubMed ID: 2324698
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.
    Maślińska D
    Acta Physiol Pol; 1984; 35(2):137-40. PubMed ID: 6443171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
    Benmansour S; Brunswick DJ
    Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
    Ravaris CL; Robinson DS; Ives JO; Nies A; Bartlett D
    Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced changes in motor activity after selective MAO inhibition.
    Gianutsos G; Carlson GM; Godfrey JG
    Pharmacol Biochem Behav; 1983 Aug; 19(2):263-8. PubMed ID: 6634874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.